Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

1.95USD
16 Jan 2019
Change (% chg)

$0.03 (+1.56%)
Prev Close
$1.92
Open
$1.90
Day's High
$2.15
Day's Low
$1.90
Volume
56,461
Avg. Vol
37,410
52-wk High
$4.56
52-wk Low
$1.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.04 -0.045
Jun '18 0.09 -0.041
Mar '18 0.15 -0.047
FY 2017 Dec '17 0.11 -0.060
Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.38
P/E High - Last 5 Yrs. -- 148.01 46.19
P/E Low - Last 5 Yrs. -- 47.79 24.58
Beta 0.85 1.08 0.91
Price to Sales (TTM) 1,110.25 49.51 6.26
Price to Book (MRQ) -- 10.16 5.20
Price to Tangible Book (MRQ) -- 13.82 6.73
Price to Cash Flow (TTM) -- 52.80 24.17
% Owned Institutions 5.90 3.75 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.93
Payout Ratio(TTM) -- 7.04 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -93.70 130.04 8.17
Sales (TTM) vs TTM 1 Yr. Ago -42.39 47.85 6.48
Sales - 5 Yr. Growth Rate -38.07 22.76 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.65 75.87 23.23
EPS (TTM) vs TTM 1 Yr. Ago 55.50 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -39.54 9.25 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 2.18 2.30
Current Ratio (MRQ) 0.94 3.43 3.12
LT Debt to Equity (MRQ) -- 18.73 11.47
Total Debt to Equity (MRQ) -- 31.43 16.03
Interest Coverage (TTM) -88.90 -43.27 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 15.24 56.29 54.45
Gross Margin - 5 Yr. Avg. 89.96 60.55 52.36
EBITD Margin (TTM) -6,209.52 -- --
EBITD - 5 Yr. Avg -383.86 -110.00 13.10
Operating Margin (TTM) -6,210.97 -184.40 6.05
Operating Margin - 5 Yr. Avg. -384.15 -126.43 8.39
Pre-Tax Margin (TTM) -6,370.48 -175.18 7.01
Pre-Tax Margin - 5 Yr. Avg. -387.78 -132.58 8.67
Net Profit Margin (TTM) -6,370.48 -181.91 3.11
Net Profit Margin - 5 Yr. Avg. -387.36 -136.98 4.86
Effective Tax Rate (TTM) -- 21.48 23.27
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,045 7,650,971 873,304,610
Net Income/Employee (TTM) -2,869,585 652,631 103,509,255
Receivable Turnover (TTM) 12.23 6.25 5.80
Inventory Turnover (TTM) 8.87 1.89 3.57
Asset Turnover (TTM) 0.21 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1,329.05 6.45 11.45
Return on Assets - 5 Yr. Avg. -530.60 5.52 12.50
Return on Investment (TTM) -- 8.99 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -- 10.13 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.36
  1 Year 3 Year 5 Year
Sales % -89.73 -56.13 -38.07
EPS (TTM) % 40.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.14 -1.38 49 98
13 Week -7.51 -12.01 36 94
26 Week -6.37 -13.49 44 98
52 Week 19.75 1.50 63 68
YTD 43.07 25.65 70 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.76%
# of Holders: 73
Total Shares Held: 4,305,404
3 Mo. Net Change: -1,566
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 3
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.